Mitsimponas Nikolaos Medical Oncologist
Education & Academic Qualifications
- Degree in Medicine, Medical School of Athens, National and Kapodistrian University of Athens with Degree “Very Good” (2004 – 2010)
- Specialty in Medical Oncology (2018)
- ESMO Examination Certificate European Society of Medical Oncology (2018)
- MSc Programme in Palliative Care, Medical School of Athens, Kapodistrian University of Athens (2019)
- Fellowship: ESMO Fellowship in Translational Research, Translational Research Unit Visit in Biomarkers, The Christie Hospital and Manchester Cancer Research Center, Manchester United Kingdom (2019)
- Department of Medical Oncology and Hematology Medical Oncology and Hematology Marien Hospital Akademisches Lehrkrankenhaus Hein-rich Heine Universität Düsseldorf, Germany. Residency in Medical Oncology (2013 -2017)
- Second Department of Medical Oncology Agios Savvas Hospital Athens. Residency in Medical Oncology (2017 – 2018)
- Department of Internal Medicine St. Josef Hospital, Hilden, Germany. Residency in Medical Oncology – General Part (2012 -2013)
Fellowship in Societies, Membership in Journal Editorial Committees
ESMO (European Society of Medical Oncology)
ASCO (American Society of Clinical Oncology)
DGHO (Deutsche Gesellschaft für Hämatologie und Onkologie)
ECCO (European Cancer Organisation)
HeSMO- Hellenic Society of Medical Oncology
Hellenic Cooperative Oncology Group (HeCOG)
Hellenic Anticancer Society
Hellenic Society of Palliative Care
AD-HOC REVIEWER for Oxford Medical Case Reports
08.2018 – now Medical Oncologist: HYGEIA & MHTERA Hospital
08.2017 – 06.2018 Resident doctor in training status in Medical On-cology Agios Savvas Hospital Athens, Greece
09.2013- 07.2017 Resident doctor in training Status in Medical On-cology and Haematology Marien Hospital Akad-emisches Lehrkrankenhaus Heinrich Heine Univer-sität Düsseldorf, Germany
01.2012- 07.2013 Resident doctor in training Status in Internal Medi-cine, St. Josef Hospital, Hilden, Germany
12.2010- 07.2011 Military Doctor in Hellenic Army
Lectures at numerous international and Greek conferences
Participation in the Campaign of Cancer Patients Coalition AgkaliaZO for the information and education of school children about skin cancer.
Regular teaching and tutoring of Undergraduate Medical Students of the University of Düsseldorf at Marien Hospital Düsseldorf (part of the University Hospital of Düsseldorf)
Clinical & Research Interest
Genitourinary tract Tuours
Gastrointestinal tract Tumours
Gynecological Tumours and Breast Cancer
Skin Cancer and Thyroid Cancer
Survivorship Care and Palliative Care
Honors & Awards
The doctor was chosen from ESMO (European Society of Medical Oncology) to participate in ESMO Fellowship in Translational Research, Translational Research Unit Visit in Biomarkers, The Christie Hospital and Manchester Cancer Research Center, Manchester United Kingdom (6.2019).
The doctor was chosen from ESMO (European Society of Medical Oncology) to be the main writer of ESMO Patient Guide on Survivorship (2017).
Mitsimponas was chosen from ESMO to participate in many preceptorship courses on colorectal cancer, prostate cancer, breast cancer, immunotherapy and brain tumours (ESMO Preceptorship on Brain Tumours, Athens, 2018, ESMO Preceptorship on Breast Cancer, Lisbon, 2017, ESMO Preceptorship on Colorectal Cancer, Valencia, 2017, ESMO Preceptorship on Immunoncology, Madrid, 2017, ESMO Preceptorship on Prostate Cancer, Lugano, 2016)
New Therapies in Oncology: Manual of Management of Adverse Events. ISBN 978-618-81321-1-5
ESMO Patient Guide on Survivorship-Greek Version. ESMO Guidelines for Patients. Nikolaos Mitsimponas & Dr. Stefan Rauh representing ESMO, with contribution of ECPC representatives Dr. Francesco De Lorenzo and Kathi Apostolidis. Greek Version edited by Dr. Nikolaos Mitsimponas and Maria Dede.
ESMO Patient Guide on Survivorship. ESMO Guidelines for Patients. Nikolaos Mitsimponas & Dr. Stefan Rauh representing ESMO, with contribution of ECPC representatives Dr. Francesco De Lorenzo and Kathi Apostolidis
Treatment of Combined Autoimmune Neutropenia and Immune Thrombocytopenia with Methotrexate. Acta Haematol. 2019 Jun 28:1-2. doi: 10.1159/000500872. Mitsogianni M., Mitsimponas N., Haase S., Giagounidis A.
Metastatic Cutaneous Squamous Cell Cancer with Peritoneal Carcinomatosis: A Case Report. Reports2019, 2(1), 8; https://doi.org/10.3390/reports2010008. Mitsimponas N., Grivas A.
Aromatase Inhibitor-Associated Tendinopathy and Muscle Tendon Rupture: Report of Three Cases of This Exceedingly Rare Adverse Event. Case Rep Oncol 2018;11:557–561Mitsimponas N. · Klouva E. · Tryfonopoulos D. · Grivas A. · Demiri S. · Koumakis G. · Gouveris P.
Isolated splenic metastasis from non-small cell lung cancer: Study of an extremely rare clinical entity with review of all cases reported in the literature. Journal of Thoracic Oncology Volume 13, Issue 4, Supplement, April 2018, Pages S123-S124. N. Mitsimponas, M. Mitsogianni, A. Giagounidis
Concomitant Non-Small Cell Lung Cancer and Hairy Cell Leukemia in a Patient Harboring BRAF-V600E Mutation in Both Tissues: A Case Report. Case Rep Oncol 2018;11:109-113. Mitsogianni M, Mitsimponas N, Crespo F, Hartmann K, A, Klosterhalfen B, Haase S, Giagounidis A.
“ESMO Patient Guide on Survivorship”, ESMO Guidelines (2017) Dr. Nikolaos Mitsimponas & Dr. Stefan Rauh representing ESMO, with contribution of ECPC representatives Dr. Francesco De Lorenzo and Kathi Apostolidis
Isolated Gallbladder Metastasis from Renal Cell Carcinoma: A Case Report and Review of the Literature. Ann Hematol Oncol. 2017; 4(5): 1149. Mitsimponas N, Crespo F, Zarras K, Diederich S, Klosterhalfen B and Giagounidis A.
Isolated Splenic Metastasis from Non-Small-Cell Lung Cancer: A Case Report and Review of the Literature. Case Rep Oncol 2017; 10:638–643. Mitsimponas N. · Mitsogianni M. · Crespo F. · Hartmann K.-A. · Diederich S. · Klosterhalfen B. · Giagounidis A.